ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Arcutis Biotherapeutics, Inc. (ARQT) Crossed Above the 50-Day Moving Average: What That Means for Investors [Yahoo! Finance]
Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 200-Day Moving Average [Yahoo! Finance]
Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average [Yahoo! Finance]
Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors [Yahoo! Finance]
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
Form 4 Arcutis Biotherapeutics, For: Nov 18 Filed by: Matsuda Masaru
Form 144 Arcutis Biotherapeutics, Filed by: Matsuda Masaru
Form 4 Arcutis Biotherapeutics, For: Nov 14 Filed by: Burnett Patrick
Form 144 Arcutis Biotherapeutics, Filed by: Burnett Patrick
Form SC 13G/A Arcutis Biotherapeutics, Filed by: Point72 Asset Management, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.